Skip to main content

Chronicle

An interventional, open-label, fixed-dose and multiple administration study to evaluate long-term treatment with Eptinezumab in…
1 December 2021

Autonomy

A phase II, double-blind, randomized, placebo-controlled study, parallel-group, multicenter research on the safety and effectiveness…
11 June 2021

Alector AD

A phase II, multicentre, double-blind, randomized, placebo-controlled study of the safety and efficacy of the…
17 March 2021

Open Road

An open-label, multicenter, follow-up study to evaluate the safety and tolerability of long-term administration of…
16 March 2021

GEMINI-II

A phase III randomized, double-blind study comparing an existing treatment (teriflunomide) with a new one…
16 March 2021

Embark

Phase IIIb, open-label, multicenter safety study of BIIB037 (aducanumab) in study participants with Alzheimer's disease…
16 March 2021

Alector FTD

A multicenter, open-label phase II study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of…
16 March 2021

Trailblazer

A phase II, double-blind, randomized, placebo-controlled trial of the safety, tolerability and effectiveness of Donanemab…
1 March 2021